Cardioxyl Pharmaceuticals, Inc.
12 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 3 name spellings.
4
Ending by 2030
May 2029
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 2 fees due Apr 13 to 17, 2027 · next Apr 13
- 1 fee due Jun 30, 2027The maintenance fee for Nitroxyl donors with improved therapeutic index (US 10,517,847) comes due Jun 30, 2027. Unpaid by Jan 3, 2028, it lapses early.
- 1 fee due Aug 4, 2027The maintenance fee for Pharmaceutical compositions comprising nitroxyl donors (US 10,548,872) comes due Aug 4, 2027. Unpaid by Feb 4, 2028, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,791,134 | Nitroso compounds as nitroxyl donors and methods of use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,725,402 | Nitroso compounds as nitroxyl donors and methods of use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,732,029 | Nitroso compounds as nitroxyl donors and methods of use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,318,705 | Nitroso compounds as nitroxyl donors and methods of use thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 8,987,326 | Nitroxyl Donors with Improved Therapeutic Index In force · High confidence | In force | High confidence | |
| US 9,156,804 | Nitroxyl donors with improved therapeutic index In force · From the USPTO record | In force | From the USPTO record | |
| US 9,586,896 | Nitroxyl donors with improved therapeutic index In force · From the USPTO record | In force | From the USPTO record | |
| US 9,968,584 | Nitroxyl donors with improved therapeutic index In force · From the USPTO record | In force | From the USPTO record | |
| US 10,213,408 | Nitroxyl donors with improved therapeutic index In force · From the USPTO record | In force | From the USPTO record | |
| US 10,245,249 | Pharmaceutical Compositions Comprising Nitroxyl Donors In force · High confidence | In force | High confidence |
Also on record, not counted in the 20: 12 patents in force now held by others · 5 lapsed for an unpaid fee · 1 surrendered on reissue. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 abandoned · 2 no status recorded